Page last updated: 2024-10-25

diazoxide and Retroperitoneal Neoplasms

diazoxide has been researched along with Retroperitoneal Neoplasms in 1 studies

Diazoxide: A benzothiadiazine derivative that is a peripheral vasodilator used for hypertensive emergencies. It lacks diuretic effect, apparently because it lacks a sulfonamide group.
diazoxide : A benzothiadiazine that is the S,S-dioxide of 2H-1,2,4-benzothiadiazine which is substituted at position 3 by a methyl group and at position 7 by chlorine. A peripheral vasodilator, it increases the concentration of glucose in the plasma and inhibits the secretion of insulin by the beta- cells of the pancreas. It is used orally in the management of intractable hypoglycaemia and intravenously in the management of hypertensive emergencies.

Retroperitoneal Neoplasms: New abnormal growth of tissue in the RETROPERITONEAL SPACE.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tucker, WR1
Ryan, WG1
Martin, BF1
Schwartz, TB1

Other Studies

1 other study available for diazoxide and Retroperitoneal Neoplasms

ArticleYear
Studies in a patient with retroperitoneal sarcoma associated with severe hypoglycemia.
    Annals of the New York Academy of Sciences, 1968, Apr-11, Volume: 150, Issue:2

    Topics: Aged; Blood Glucose; Diazoxide; Female; Glucagon; Glucose Tolerance Test; Humans; Hypoglycemia; Infu

1968